thymalfasin and Liver-Diseases

thymalfasin has been researched along with Liver-Diseases* in 2 studies

Reviews

2 review(s) available for thymalfasin and Liver-Diseases

ArticleYear
Thymalfasin: an immune system enhancer for the treatment of liver disease.
    Journal of gastroenterology and hepatology, 2004, Volume: 19 Suppl 6

    Thymalfasin (thymosin-alpha 1) is an immunomodulating agent able to enhance the Th1 immune response. It has been evaluated for its immunomodulatory activities and related therapeutic potential in several diseases, including chronic hepatitis B and C, AIDS, primary immunodeficiency diseases, depressed response to vaccination and cancer. The basis for effectiveness in these conditions is primarily through modulation of immunological responsiveness, as thymalfasin has been shown to have beneficial effects on numerous immune system parameters and to increase T-cell differentiation and maturation. Thymalfasin is responsible for reconstitution of immune function when thymic tissue is given back to thymectomized animals. In addition, thymalfasin has been shown to have efficacy in multiple experimental models of immune dysfunction, mainly, infectious diseases such as hepatitis (woodchuck) and influenza (mouse), and cancer such as melanoma (mouse) and colorectal carcinoma (rat) where thymalfasin has shown antitumor effects.

    Topics: Amino Acid Sequence; Animals; Antiviral Agents; Apoptosis; Cytokines; Histocompatibility Antigens Class I; Humans; Immunologic Factors; Liver Diseases; Lymphocytes; Lymphopoiesis; Molecular Sequence Data; Thymalfasin; Thymosin; Virus Replication

2004
Thymalfasin: an immune system enhancer for the treatment of liver disease.
    Journal of gastroenterology and hepatology, 2004, Volume: 19, Issue:12

    Thymalfasin (thymosin-alpha 1) is an immunomodulating agent able to enhance the Thl immune response. It has been evaluated for its immunomodulatory activities and related therapeutic potential in several diseases, including chronic hepatitis B and C, AIDS, primary immunodeficiency diseases, depressed response to vaccination and cancer. The basis for effectiveness in these conditions is primarily through modulation of immunological responsiveness, as thymalfasin has been shown to have beneficial effects on numerous immune system parameters and to increase T-cell differentiation and maturation. Thymalfasin is responsible for reconstitution of immune function when thymic tissue is given back to thymectomized animals. In addition, thymalfasin has been shown to have efficacy in multiple experimental models of immune dysfunction, mainly, infectious diseases such as hepatitis (woodchuck) and influenza (mouse), and cancer such as melanoma (mouse) and colorectal carcinoma (rat) where thymalfasin has shown antitumor effects.

    Topics: Adjuvants, Immunologic; Humans; Liver Diseases; Thymalfasin; Thymosin; Virus Diseases

2004